CLINICAL TRIALS PROFILE FOR PANTOPRAZOLE SODIUM
✉ Email this page to a colleague
All Clinical Trials for Pantoprazole Sodium
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00141817 ↗ | Study Evaluating Pantoprazole in Children With GERD | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | 2005-08-01 | The purpose of this study is to characterize the PK profile, safety and tolerability of single and multiple doses of pantoprazole in children aged 1 through 11 years with endoscopically proven GERD. |
NCT00259012 ↗ | Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD | Completed | Nycomed | Phase 3 | 2005-11-01 | The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profiles to determine the safety and tolerability of single and multiple doses of pantoprazole in infants aged 1 through 11 months. |
NCT00259012 ↗ | Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | 2005-11-01 | The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profiles to determine the safety and tolerability of single and multiple doses of pantoprazole in infants aged 1 through 11 months. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Pantoprazole Sodium
Condition Name
Clinical Trial Locations for Pantoprazole Sodium
Trials by Country
Clinical Trial Progress for Pantoprazole Sodium
Clinical Trial Phase
Clinical Trial Sponsors for Pantoprazole Sodium
Sponsor Name